4.7 Article

Mechanism of two alkaloids isolated from coral endophytic fungus for suppressing angiogenesis in atherosclerotic plaque in HUVEC

Journal

INTERNATIONAL IMMUNOPHARMACOLOGY
Volume 109, Issue -, Pages -

Publisher

ELSEVIER
DOI: 10.1016/j.intimp.2022.108931

Keywords

Coral endophytic fungus; Atherosclerosis; Angiogenesis; Oxidized low-density lipoproteins; Inflammation

Funding

  1. 2020 Shenzhen International Scientific and Technological Cooperation R D Project [GJHZ20190823111601682]
  2. Basic Research Project of Shenzhen Science and Technology Innovation Commission [JCYJ20190813105005619]
  3. Shenzhen Dapeng New District Indus-trial Development Fund [KY20180203]
  4. Shenzhen Dapeng New District Scientific and Technological Research and Development Fund [KJYF202001-07]
  5. Guangdong Basic and Applied Basic Research Foundation [2020A1515011075]
  6. Natural Science Foundation of Guangdong Province [2018A030307046]
  7. Development Project about Marine Economy Demonstration of Zhanjiang City [XM-202008-01B1]
  8. Southern Marine Science and Engineering Guangdong Laboratory (Zhanjiang) [ZJW-2019-07]

Ask authors/readers for more resources

This study found that two alkaloids, EAA and AZN, from endophytic fungus Aspergillus terreus C23-3, derived from coral Pavona, can effectively prevent HUVEC damage and angiogenesis induced by oxidized low-density lipoproteins (oxLDL) by inhibiting inflammation and apoptosis. Therefore, these alkaloids may have potential beneficial effects in regulating atherosclerosis and plaque angiogenesis.
Atherosclerosis is a significant cause of many cardiovascular diseases. Oxidized low-density lipoproteins (oxLDL) are crucial in developing atherosclerosis. In this study, we researched the effects of two alkaloids epiaszonalenin A (EAA) and aszonalenin (AZN) of an endophytic fungus Aspergillus terreus C23-3 from coral Pavona, on ox-LDL-induced inflammation, apoptosis and angiogenesis in HUVEC, and evaluated related factors and mechanism. The results reveal that EAA and AZN inhibit HUVEC migration, invasion, angiogenesis and reactive oxygen species (ROS) accumulation on a non-cytotoxic basis. Then, EAA and AZN suppressed the ox-LDL-induced of LOX-1, VEGF protein expression, MAPK and PI3K/AKT pathways phosphorylation. Furthermore, AZN suppressed the ox-LDL-induced inflammatory factors (IL-6, IL-1 beta, and TNF-alpha), intercellular adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule-1 (VCAM-1) and VEGF receptor VEGFR-2 and platelet-derived growth factor PDGF. In addition, it inhibited ox-LDL-induced atherosclerosis by blocking inflammation and apoptosis through nuclear factor kappa B (NF-kappa B), cleaved-caspase-3 and Bax/Bcl-2 pathways. Molecular docking results confirm that the effect of AZN on atherosclerosis inhibitory activity may be attributed to hydrogen bonds formed into LOX-1 and VEGFR-2. These data indicate that EAA and AZN can effectively prevent ox-LDL-induced HUVEC damage and angiogenesis by inhibiting inflammation and apoptosis. Therefore, EAA and AZN may have potential beneficial effects in regulating atherosclerosis and plaque angiogenesis.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available